Aging Analytics Agency is the world’s premier provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Aging, and the convergence of technologies such as AI, Blockchain, Digital Health and their impact on the healthcare industry.
The company provides strategic consulting services in fields relating to Longevity, and currently serves as the primary source of analytics and data for the UK All-Party Parliamentary Group for Longevity.
Aging Analytics Agency is the only analytics company focused exclusively on the topics of Aging, Geroscience, and Longevity. Founded in 2013, with headquarters in London, UK and branches in Europe, US and Canada, it began producing in-depth reports on Longevity long before it emerged as an industry.
In 2014, it successfully predicted the boom in industry development and financing rounds that occurred in 2017-2018, three years in advance, at a time when the vast majority of investors, business analysts, and even geroscientists believed its emergence to be in the next decade.
The company has also established reputation for developing sophisticated, highly multidimensional comparative analytics framework for the Longevity, Regenerative Medicine and Precision Preventive Medicine industries, as well as the rising sector of Longevity Financial Industry, allowing for practical and tangible forecasts to be applied to industries that are otherwise too complex for standard analytical approaches to be used in a relevant way.
It has been developing enhanced iterations of its proprietary analytics system since 2015, and will serve as the main source for data for the soon-to-be-launched specialized Longevity index hedge fund Longevity.Capital, helping to establish pragmatic portfolio company valuation and efficient due-diligence procedures, and to structure advanced investment strategy in the overly-complex Longevity industry.
In 2019, Aging Analytics Agency significantly enhanced its executive management team with the addition of several prominent Longevity industry experts and specialists, including the appointment of Eric Kilhstrom as the new Director, former Interim Director of the UK Government-led £98 million Healthy Ageing Industrial Strategy Challenge Fund.